Story

Corning Stock Slides on High Valuation, Insider Sales, and Bearish Bets

ENTHMSVIIDZHZH-TWJAKOHI
Jul 15, 20261 min read
Corning Stock Slides on High Valuation, Insider Sales, and Bearish Bets

Summary

Shares of Corning Inc. fell sharply, extending a multi-week correction as investors weigh a stretched valuation, significant executive stock sales, and bearish options activity ahead of quarterly earnings.

Text size
Background

Shares of Corning (NYSE: GLW) dropped 7.4% in morning trading on Monday, accelerating a significant pullback from the stock's recent all-time high. The decline occurred even as the broader U.S. market posted modest gains, indicating the selling pressure is specific to the company.

Drivers of the Decline

The sell-off appears to be driven by a confluence of factors that have raised investor concerns following a sharp rally earlier in the year. The stock has been in a corrective phase since hitting a peak of $271.78 on June 30.

Key pressures on the stock include:

  • Stretched Valuation: After a rapid, AI-driven run-up, Corning’s trailing price-to-earnings ratio had expanded to over 90x, a level substantially higher than its five-year historical median, making it vulnerable to profit-taking.
  • Insider Selling: Recent SEC filings revealed that top executives, including CEO Wendell Weeks, sold more than $54 million worth of shares near the stock's peak prices, with no offsetting insider purchases reported.
  • Bearish Options Activity: Traders identified an unusually large purchase of weekly put options in the prior session. This type of derivatives activity signals that some institutional investors may be positioning for further downside ahead of the company's second-quarter earnings report.
Sample IUX Markets – In-articleAd

Upcoming Earnings and Technical Outlook

Corning is scheduled to release its Q2 financial results on July 28. Analysts are forecasting core earnings per share of approximately $0.75–$0.76 on revenue near $4.60 billion. However, a history of revenue misses in several recent quarters has heightened sensitivity to any potential disappointment.

The recent wave of selling has pushed the stock price toward the $173–$174 range. Analysts have previously identified this area as a key technical support level based on moving averages, which will be closely watched by traders as a potential floor for the stock.

Read next

More on Stocks
Shenzhen-Listed Jingxin Pharmaceutical Refiles for Hong Kong IPO

Stocks

Shenzhen-Listed Jingxin Pharmaceutical Refiles for Hong Kong IPO

Sep 20, 2026

Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ) has resubmitted its application for a main board listing on the Hong Kong Stock Exchange, aiming to secure a dual listing to access international capital. The company specializes in drugs for central nervous system and cardiovascular diseases.

Back to latest news

LATEST